133 related articles for article (PubMed ID: 35936524)
1. The Effect of
Nikmohammadi N; Sarbakhsh P; Moazami Goudarzi M; Talebi M; Farshdousti-Hagh M; Malakouti J; Gilani N
Iran J Public Health; 2022 Apr; 51(4):895-903. PubMed ID: 35936524
[TBL] [Abstract][Full Text] [Related]
2. The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping.
Moazami-Goudarzi M; Farshdousti-Hagh M; Hoseinpour-Feizi A; Talebi M; Movassaghpour-Akbari AA; Shams-Asanjan K; Eyvazi-Ziyaee J; Seifi M
Caspian J Intern Med; 2016; 7(2):105-13. PubMed ID: 27386062
[TBL] [Abstract][Full Text] [Related]
3. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
4. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
5. BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach.
Chatterjee K; De S; Deb Roy S; Sahu SK; Chakraborty A; Ghatak S; Das N; Mal S; Roy Chattopadhyay N; Das P; Reddy RR; Mukherjee S; Das AK; Puii Z; Zomawia E; Singh YI; Tsering S; Riba K; Rajasubramaniam S; Suryawanshi AR; Choudhuri T
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1171-1181. PubMed ID: 33906310
[TBL] [Abstract][Full Text] [Related]
6. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
Nückel H; Frey UH; Bau M; Sellmann L; Stanelle J; Dürig J; Jöckel KH; Dührsen U; Siffert W
Blood; 2007 Jan; 109(1):290-7. PubMed ID: 16960146
[TBL] [Abstract][Full Text] [Related]
7. Correlations of IL-6 and IL-10 gene polymorphisms with childhood acute lymphoblastic leukemia.
Liu RT; Wang XX; Sun JR; Gao N; Yu WZ
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8048-8056. PubMed ID: 32767331
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
Stamati L; Avgeris M; Kosmidis H; Baka M; Anastasiou T; Piatopoulou D; Scorilas A; Gourgiotis D
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2023-36. PubMed ID: 25982455
[TBL] [Abstract][Full Text] [Related]
9. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL).
Addeo R; Caraglia M; Baldi A; D'Angelo V; Casale F; Crisci S; Abbruzzese A; Vincenze B; Campioni M; Di Tullio MT; Indolfi P
Cancer Biol Ther; 2005 Jan; 4(1):32-8. PubMed ID: 15684603
[TBL] [Abstract][Full Text] [Related]
11. Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia.
Narayan S; Chandra J; Sharma M; Naithani R; Sharma S
Hematology; 2007 Feb; 12(1):39-43. PubMed ID: 17364991
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis Induced by Prednisolone Occurs without Altering the Promoter Methylation of BAX and BCL-2 Genes in Acute Lymphoblastic Leukemia Cells CCRF-CEM.
Ganbarjeddi S; Azimi A; Zadi Heydarabad M; Hemmatzadeh M; Mohammadi S; Mousavi Ardehaie R; Zamani M; Baharaghdam S; Esmaeili S; Ghasemi A
Asian Pac J Cancer Prev; 2020 Feb; 21(2):523-529. PubMed ID: 32102534
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of BAX and BCL-2 Gene Expression and Apoptosis Induction in Acute Lymphoblastic Leukemia Cell Line CCRFCEM after High- Dose Prednisolone Treatment.
Ghasemi A; Khanzadeh T; Zadi Heydarabad M; Khorrami A; Jahanban Esfahlan A; Ghavipanjeh S; Gholipour Belverdi M; Darvishani Fikouhi S; Darbin A; Najafpour M; Azimi A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2319-2323. PubMed ID: 30141309
[TBL] [Abstract][Full Text] [Related]
15. A Study Investigating the Role of 2 Candidate SNPs in Bax and Bcl-2 Genes in Alzheimer's Disease.
Erdal ME; Görücü Yilmaz S; Ay ME; Güler Kara H; Avci Özge A; Tasdelen B
P R Health Sci J; 2020 Sep; 39(3):264-269. PubMed ID: 33031695
[TBL] [Abstract][Full Text] [Related]
16. The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia.
Salomons GS; Brady HJ; Verwijs-Janssen M; Van Den Berg JD; Hart AA; Van Den Berg H; Behrendt H; Hählen K; Smets LA
Int J Cancer; 1997 Jun; 71(6):959-65. PubMed ID: 9185697
[TBL] [Abstract][Full Text] [Related]
17. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Nrf2, Keap1 and Apoptotic Pathway Genes Expression in Acute Myeloid Leukemia Patients.
Jalali A; Mahmoudi S; Larki Harchegani A; Mohammadiasl J; Ahmadzadeh A
Iran J Pharm Res; 2021; 20(1):398-407. PubMed ID: 34400968
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic effect of resveratrol on human T-ALL cell line CCRF-CEM is unlikely exerted through alteration of BAX and BCL2 promoter methylation.
Zadi Heydarabad M; Vatanmakanian M; Abdolalizadeh J; Mohammadi H; Azimi A; Mousavi Ardehaie R; Movasaghpour A; Farshdousti Hagh M
J Cell Biochem; 2018 Dec; 119(12):10033-10040. PubMed ID: 30132966
[TBL] [Abstract][Full Text] [Related]
20. Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia.
Hogarth LA; Hall AG
Blood; 1999 Apr; 93(8):2671-8. PubMed ID: 10194447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
